Results 11 to 20 of about 490,601 (215)

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

Diagnostics, 2020
Hyperthermic intraperitoneal chemotherapy (HIPEC) in conjunction with cytoreductive surgery (CRS) holds promise as an adjunctive treatment strategy in malignancies affecting the peritoneal surface, effectively targeting remaining microscopic residual ...
McKayla J. Riggs, Prakash K. Pandalai, Joseph Kim, Charles S. Dietrich   +3 more
doaj   +2 more sources

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations

Cancer Management and Research, 2019
Laura M Enomoto, Perry Shen, Edward A Levine, Konstantinos I VotanopoulosWake Forest Baptist Medical Center, Medical Center Boulevard, Winston Salem, NC 27157, USAAbstract: Malignant peritoneal mesothelioma (MPM) is a rare, aggressive malignancy that ...
Enomoto LM, Shen P, Levine EA, Votanopoulos KI   +3 more
doaj   +1 more source

Current Status of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer (CRC). [PDF]

South Asian J Cancer
Abstract Accounting for 8.7% of global cancer deaths, colorectal cancer (CRC) is one of the leading causes of cancer-related mortality. Cytoreduction surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is part of a multimodal strategy for managing CRC.
Somashekhar SP, Surendran AK, Goyal D, Rawat S, Aggarwal S, Selvasekar C, Parikh PM.   +6 more
europepmc   +5 more sources

Effect of hyperthermia on improving neutrophil restoration after intraperitoneal chemotherapy

International Journal of Hyperthermia, 2019
Purpose: Intraperitoneal (IP) chemotherapy has several benefits but also can have severe hematologic side effects. We compared the effects of hyperthermic intraperitoneal chemotherapy (HIPEC) and conventional IP chemotherapy on bone marrow suppression ...
Wan-Chun Huang, Chao-Chih Wu, Yun-Ting Hsu, Chih-Long Chang   +3 more
doaj   +2 more sources

Is hyperthermic intraperitoneal chemotherapy (HIPEC) safe for healthcare workers?

Surgical Oncology, 2017
During hyperthermic intraperitoneal chemotherapy (HIPEC), caregivers are exposed by different routes to cytotoxic drugs. This review proposes an overview of the safety of HIPEC by assessing existing data on protection procedures, biological and non-biological samples.
Rodier, Simon, Saint-Lorant, Guillaume, Guilloit, Jean-Marc, Palix, Agnès, Divanon, Fabienne, Sichel, François, Delépée, Raphaël   +6 more
openaire   +4 more sources

The role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer

Gynecologic Oncology
Hyperthermic intraperitoneal chemotherapy (HIPEC) is increasingly recognized as an effective addition to cytoreductive surgery in advanced ovarian cancer, particularly in patients who respond to platinum-based chemotherapy.A systematic review of phase III randomized controlled trials testing the role of HIPEC in ovarian cancer was performed, according ...
Bogani G., Fagotti A., Chiantera V., De Iaco P., Vizza E., Scollo P., Petrillo M., Giannini A., Di Donato V., Raspagliesi F., Vizzielli G.   +10 more
openaire   +5 more sources

Salvage hyperthermic intraperitoneal chemotherapy for appendiceal mucinous adenocarcinoma with peritoneal mucinous carcinomatosis

Journal of Cancer Research and Practice, 2018
Appendiceal tumors, particularly those with patterns of advanced malignancy, are rare in clinical practice. This study describes a patient with a mucinous adenocarcinoma originating from the appendix, who also had disseminated peritoneal carcinomatosis ...
Sheng-Cheng Wu, Yu-Guang Chen, Ren-Hua Ye, Jia-Hong Chen, Yi-Ying Wu, Ping-Ying Chang, Ming-Shen Dai, Yeu-Chin Chen, Ching-Liang Ho, Tzu-Chuan Huang   +9 more
doaj   +2 more sources

Efficacy of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Management of Malignant Ascites [PDF]

World Journal of Surgical Oncology, 2020
Abstract Objective: The purpose of this study is to compare the difference of clinical efficacy between conventional intraperitoneal chemotherapy and HIPEC, so as to explore the clinical application value and advantages of HIPEC. Design: A retrospective analysis was conducted on 80 patients with malignant ascites admitted to our hospital from ...
Jie Jiao, Chengzhen Li, Guanying Yu, Lei Zhang, Xiaoyan Shi, Jingdu Yan, Houjun Zhang, Peiming Guo   +7 more
openaire   +3 more sources

Hyperthermic intraperitoneal chemotherapy (HIPEC) after primary debulking surgery in advanced epithelial ovarian cancer: is BRCA mutational status making the difference? [PDF]

, 2022
The role of a molecular pattern predictive of hyperthermic intraperitoneal chemotherapy (HIPEC) efficacy in advanced ovarian cancer (AOC) patients has been poorly investigated.
D'Indinosante, Marco, Scambia, Giovanni, Giudice, Maria Teresa, Fagotti, Anna, Bernardini, Federica, Ghirardi, Valentina, De Felice, Francesca   +6 more
core   +1 more source

There is no role for hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer

International Journal of Gynecological Cancer, 2022
The hype around hyperthermic intraperitoneal chemotherapy (HIPEC) started two decades ago when a randomized trial comparing surgery and HIPEC against palliative chemotherapy only in patients with colorectal cancer showed favorable results. In ovarian cancer, data from three prospective randomized controlled trials and several retrospective trials are ...
Richard Schwameis, Luis Chiva, Philipp Harter   +2 more
openaire   +3 more sources